促血栓纤维蛋白凝块特性可预测无诱因静脉血栓栓塞后的隐匿性癌症
该队列研究纳入369例70岁以下、常规筛查未检出恶性肿瘤的无诱因静脉血栓栓塞患者,在停用抗凝后中位4个月检测血浆凝块通透性(Ks)、凝块溶解时间(CLT)及促血栓标志物。中位随访37个月期间22例(6%)诊断为恶性肿瘤,该组Ks降低13%、CLT延长25.5%、内源性凝血酶生成潜能(ETP)升高7%、可溶性P-选择素升高40.3%、H3Cit升高169.2%。低Ks与长CLT的促血栓凝块表型患者癌症诊断风险最高(HR 23.4,95%CI 6.67-82.15)。
要点
- 无诱因VTE后低Ks与长CLT的促血栓凝块表型与随访期癌症诊断风险最高相关(HR 23.4)。
- 随访期诊断癌症者较未诊断者Ks降低13%、CLT延长25.5%、ETP升高7%、sP-选择素升高40.3%。
- 随访中位37个月,369例中22例(6%)诊断恶性肿瘤,诊断者年龄更大。
核心结论
- 无诱因VTE后的促血栓凝块特性可能有助于识别随访前3年内有癌症诊断风险的患者。
研究设计与样本
- 队列研究,纳入369例70岁以下、常规筛查未检出恶性肿瘤的无诱因VTE连续患者。
主要发现
- 中位随访37个月(IQR 33-39)期间22例(6%)诊断恶性肿瘤,该组年龄更大。
- 癌症诊断组较未诊断组:Ks降低13%、CLT延长25.5%、ETP升高7%、可溶性P-选择素升高40.3%、H3Cit升高169.2%。
- Ks与CLT分别与H3Cit相关(r=-.58和r=.31,P<.05)。
- Kaplan-Meier分析显示低Ks(第一四分位,≤6.2×10-9 cm2)、长CLT(最高四分位,>106 min)和高ETP(最高四分位,>1657 nM×min)为随访期癌症诊断的预测因素。
- 多变量Cox模型显示低Ks且长CLT的促血栓凝块表型患者癌症诊断风险最高(HR 23.4,95%CI 6.67-82.15)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Compact fibrin clots relatively resistant to lysis are observed in patients at increased risk of venous thromboembolism (VTE) including malignancy. The citrullinated histone H3 (H3Cit) predicts VTE in cancer patients. OBJECTIVES: We performed a cohort study to investigate whether abnormal clot properties predict cancer diagnosis following unprovoked VTE. METHODS: In 369 consecutive patients aged <70 years without malignancy detected during routine screening, we determined plasma clot permeability (Ks ) and clot lysis time (CLT), along with several prothrombotic markers and H3Cit after 2 to 8 months since VTE. RESULTS: During follow-up (median, 37; interquartile range, 33-39 months), malignancy was diagnosed in 22 patients (6%), who were older. This group had denser fibrin networks (-13% Ks ), impaired fibrinolysis (+25.5% CLT), increased endogenous thrombin potential (ETP,+7%), soluble P-selectin (+40.3%), and H3Cit (+169.2%) measured off anticoagulation after median 4 months since VTE. The Ks and CLT correlated with H3Cit (r = -.58 and r = .31, P < .05, respectively). The Kaplan-Meier survival analysis showed that reduced Ks (the first quartile, ≤6.2 × 10-9 cm2 ), prolonged CLT (the top quartile, >106 min), and higher ETP (the top quartile, >1657 nM × min) were predictors of cancer diagnosed during follow-up. The multivariable Cox proportional hazards model showed that patients with the prothrombotic clot phenotype (low Ks and long CLT) had the highest risk of cancer diagnosis [hazard ratio(HR), 23.4; 95% confidence interval (CI), 6.67-82.15]. CONCLUSIONS: Prothrombotic clot properties following unprovoked VTE might help identify patients at risk of a diagnosis of cancer within the first 3 years of follow-up.
引用
- Mrozinska S, Cieslik J, Broniatowska E, et al. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism. J Thromb Haemost. 2019. PMID: 31323706. doi:10.1111/jth.14579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。